The study was funded by Novo Nordisk
How to qualify for semaglutide: bottom line Semaglutide can be an effective tool for managing weight, type 2 diabetes, and even reducing certain cardiovascular and kidney or liver risksbut it isnt for everyone
The question of combining phentermine with other medications requires careful evaluation because of these extensive interaction risks
While cholesterol reduction was not the primary endpoint, the overall cardiovascular benefit reflects improvements in multiple risk factors, including lipid panels, blood pressure, and inflammation markers
That said, it's always best to consult a dietitian or healthcare professional for medical advice
Many providers consider it the next evolution of GLP-1 therapy